Cdh10 expression was not different throughout the subsets, while a lower expression of Tbc1d9 (p < 0.001) was observed in the ER-negative basal-type and HER2+ breast cancers (p < 0.05) (Figure 6D-E). Using Kaplan-Meier survival curves (https://kmplot.com/analysis/) for distant metastasis free survival (DMFS) for breast cancer, higher expression of Cdh10 was associated with worse DMFS. Here, TBC1D9 is linked to breast cancer.